Updates are available Correction dated 2024-04-03
Click to view Correction: https://doi.org/10.1007/s11307-024-01916-y
-
Authors
Petty, Alice http://orcid.org/0000-0001-7058-4185
Garcia-Hidalgo, Anna
Halff, Els F
Natesan, Sridhar
Withers, Dominic J
Irvine, Elaine E
Kokkinou, Michelle
Wells, Lisa A
Bonsall, David R
Tang, Sac-Pham
Veronese, Mattia
Howes, Oliver D
- License Information
-
More Information
Article History
Received: 7 August 2023
Revised: 26 September 2023
Accepted: 5 October 2023
First Online: 23 October 2023
Change Date: 3 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11307-024-01916-y
Declarations
:
: LW is an associate editor of Molecular Imaging and Biology (MIBI; unpaid). LW is on the leadership committee of Women in Molecular Imaging, which is part of the World Molecular Imaging Society (unpaid). LW has stock with Glaxosmithkline, and is a fulltime employee of Invicro LLC. MV and OH are named inventors for the patent “Dopaminergic Imaging to Predict Treatment Response in Mental Illness” ref: US20230024712A1. OH is also part-time employee and stock-holder of H Lundbeck A/s. OH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Karuna, Lundbeck, Neurocrine, Ontrack/Pangea, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan. No other authors have competing interests to declare.
